DPhil research opportunities 2024
The admissions cycle for entry in October 2024 is now open. Please continue to check this webpage for new opportunities as they are added. Please contact the supervisor to check that the research opportunity is still available.
Title | |
---|---|
Andersson Group - Occult hepatitis B virus infection (OBI) in people who donate blood: virology, immunology and liver health (OPAL) Andersson Group - Occult hepatitis B virus infection (OBI) in people who donate blood: virology, immunology and liver health (OPAL) | Monique Andersson |
Simmons Group - Characterising Human Intestinal Development and Dysregulation in Childhood Diseases Simmons Group - Characterising Human Intestinal Development and Dysregulation in Childhood Diseases | Alison Simmons |
Antanaviciute Group - Characterising spatial tissue niches in human immune system development and disease using computational biology, machine learning and multi-omics approaches Antanaviciute Group - Characterising spatial tissue niches in human immune system development and disease using computational biology, machine learning and multi-omics approaches | Agne Antanaviciute |
Koohy Group - Applications of multi-omics and AI to decode T cell recognition code in time and space Koohy Group - Applications of multi-omics and AI to decode T cell recognition code in time and space | Hashem Koohy |
Kini Group - A network approach to identifying novel genes causing neurodevelopmental disorders- The SATB pathway Kini Group - A network approach to identifying novel genes causing neurodevelopmental disorders- The SATB pathway | Usha Kini |
Tyler Group - Development and Application of Hyperpolarized Magnetic Resonance Imaging in the Study of the Diseased Heart Tyler Group - Development and Application of Hyperpolarized Magnetic Resonance Imaging in the Study of the Diseased Heart | Damian Tyler |
Chakraverty Group - Design of advanced haematopoietic stem cell and T cell therapies Chakraverty Group - Design of advanced haematopoietic stem cell and T cell therapies | Ronjon Chakraverty |
Antoniades Group - Cross-talk between adipose tissue and the cardiovascular system in humans: Using Artificial Intelligence to design precision Imaging diagnostics and discover novel therapeutic targets Antoniades Group - Cross-talk between adipose tissue and the cardiovascular system in humans: Using Artificial Intelligence to design precision Imaging diagnostics and discover novel therapeutic targets | Charalambos Antoniades |
Douglas Group - Functional coronary artery disease genetics - defining the function of new causal atherosclerosis genes Douglas Group - Functional coronary artery disease genetics - defining the function of new causal atherosclerosis genes | Gillian Douglas |
Karpe Group - Human fat distribution and metabolic disease Karpe Group - Human fat distribution and metabolic disease | Fredrik Karpe |
Cai Group - Inflammatory infiltration induces cancer-associated fibroblast differentiation Cai Group - Inflammatory infiltration induces cancer-associated fibroblast differentiation | Shijie Cai |
Leeson Group - Imaging in Preventive Cardiology Research Leeson Group - Imaging in Preventive Cardiology Research | Paul Leeson |
Reilly Group - Adverse myocardial remodelling in cardiac fibrosis and atrial fibrillation Reilly Group - Adverse myocardial remodelling in cardiac fibrosis and atrial fibrillation | Svetlana Reilly |
Tzima Group - Why does turbulent blood flow cause cardiovascular disease? Tzima Group - Why does turbulent blood flow cause cardiovascular disease? | Ellie Tzima |
Watkins Group – Various projects relating to inherited heart muscle disease Watkins Group – Various projects relating to inherited heart muscle disease | Hugh Watkins |
Drakesmith Group - Iron Biology Drakesmith Group - Iron Biology | Hal Drakesmith |
Goriely Group - De Novo Mutations and Human Disease Goriely Group - De Novo Mutations and Human Disease | Anne Goriely |
Higgs Group - Understanding the principles of gene expression in health and disease. Higgs Group - Understanding the principles of gene expression in health and disease. | Douglas Higgs |
Mead Group - Inflammation in p53 mutant myeloproliferative neoplasms Mead Group - Inflammation in p53 mutant myeloproliferative neoplasms | Adam Mead |
Psaila Group - Developing improved models of normal and malignant blood cell development Psaila Group - Developing improved models of normal and malignant blood cell development | Bethan Psaila |
Vyas Group - New Immune Therapies For Acute Myeloid Leukaemia (AML) And Myeloid Blood Cancers. Vyas Group - New Immune Therapies For Acute Myeloid Leukaemia (AML) And Myeloid Blood Cancers. | Paresh Vyas |
Twigg Group - Building the skull – normal and abnormal development Twigg Group - Building the skull – normal and abnormal development | Stephen Twigg |
Nerlov Group - Single Cell Biology and Genetics of Hematopoietic Stem- and Progenitor cells in Blood Cancer and Ageing Nerlov Group - Single Cell Biology and Genetics of Hematopoietic Stem- and Progenitor cells in Blood Cancer and Ageing | Claus Nerlov |
Toepfer Group - Elucidating the role of disease modifying gene variants in inherited cardiomyopathies using induced pluripotent stem cell derived cardiomyocytes and CRISPR/Cas-9 Toepfer Group - Elucidating the role of disease modifying gene variants in inherited cardiomyopathies using induced pluripotent stem cell derived cardiomyocytes and CRISPR/Cas-9 | Christopher Toepfer |
Hyde Group - Airway Gene Therapy - Engineering Lentiviral Vectors for Lung Cell-Specific Targeting Hyde Group - Airway Gene Therapy - Engineering Lentiviral Vectors for Lung Cell-Specific Targeting | Stephen Hyde |
Chapman Group - Homologous recombination in genome maintenance and cancer prevention Chapman Group - Homologous recombination in genome maintenance and cancer prevention | Ross Chapman |
Zhang Group - AI deep generative models for contrast enhancement of MRI: Towards needle-free and more informative MRI examination of the heart Zhang Group - AI deep generative models for contrast enhancement of MRI: Towards needle-free and more informative MRI examination of the heart | Qiang Zhang |
Pavlides Group - Non-invasive tests for the prediction of clinical outcomes in people with metabolic dysfunction associated steatotic liver disease Pavlides Group - Non-invasive tests for the prediction of clinical outcomes in people with metabolic dysfunction associated steatotic liver disease | Michael Pavlides |
Grist group - Development and combination of advanced neuroimaging to understand functional changes in Multiple Sclerosis Grist group - Development and combination of advanced neuroimaging to understand functional changes in Multiple Sclerosis | James Grist |
Davies Group – Genomics and Genome Editing Davies Group – Genomics and Genome Editing | James Davies |
Davis Group - Therapeutic opportunities emerging from studies of immune checkpoints Davis Group - Therapeutic opportunities emerging from studies of immune checkpoints | Simon Davis |
Vyas Group - Single Cell Biology, Molecular Mechanisms And Genetics of Transformation of Clonal Haemopoiesis to Myeloid Blood Cancer (MDS and AML) Vyas Group - Single Cell Biology, Molecular Mechanisms And Genetics of Transformation of Clonal Haemopoiesis to Myeloid Blood Cancer (MDS and AML) | Paresh Vyas |
David Hodson Group - Understanding how glucagon-like peptide-1 (GLP1) and gastric inhibitory polypeptide (GIP) receptors contribute to metabolism in complex tissues David Hodson Group - Understanding how glucagon-like peptide-1 (GLP1) and gastric inhibitory polypeptide (GIP) receptors contribute to metabolism in complex tissues | David Hodson |
Reader Group - How do protein making factories prevent cardiovascular disease? Reader Group - How do protein making factories prevent cardiovascular disease? | John Reader |
Ormondroyd Group - Development of genetic therapies for cardiomyopathy: creating an evidence base for ethical and clinical implementation. Ormondroyd Group - Development of genetic therapies for cardiomyopathy: creating an evidence base for ethical and clinical implementation. | Elizabeth Ormondroyd |
Royston Group - Advanced early detection of lytic bone disease using multi-modal computational analysis of bone marrow biopsies and skeletal imaging Royston Group - Advanced early detection of lytic bone disease using multi-modal computational analysis of bone marrow biopsies and skeletal imaging | |
Patel, de Bruijn and Roy Groups - Impact of endogenous DNA damage and repair in early haematopoiesis Patel, de Bruijn and Roy Groups - Impact of endogenous DNA damage and repair in early haematopoiesis | KJ Patel |
Leeson Group - Developing new echocardiography diagnostics with AI Leeson Group - Developing new echocardiography diagnostics with AI | Paul Leeson |
Valkovič Group - Non-invasive cardiac metabolism assessment using ultra-high field (7T) MR Spectroscopy Valkovič Group - Non-invasive cardiac metabolism assessment using ultra-high field (7T) MR Spectroscopy | Ladislav Valkovic |
Akbar Group - Generating extracellular vesicles for therapeutic Immunomodulation and building tools to determine their diagnostic potential. Akbar Group - Generating extracellular vesicles for therapeutic Immunomodulation and building tools to determine their diagnostic potential. | Naveed Akbar |